SEER Key Statistics, Chart & Performance
The current stock price of SEER is 1.77 USD. In the past month the price decreased by -9.23%. In the past year, price decreased by -23.38%.
SEER Technical Analysis
SEER Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to SEER. SEER has a great financial health rating, but its profitability evaluates not so good.
SEER Financial Highlights
Over the last trailing twelve months SEER reported a non-GAAP Earnings per Share(EPS) of -1.36. The EPS decreased by -4.62% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -25.46% | ||
| ROE | -28.48% | ||
| Debt/Equity | 0 |
SEER Forecast & Estimates
7 analysts have analysed SEER and the average price target is 3.06 USD. This implies a price increase of 72.88% is expected in the next year compared to the current price of 1.77.
For the next year, analysts expect an EPS growth of 5.9% and a revenue growth 20.41% for SEER
SEER Ownership
SEER Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 21.75 | 205.423B | ||
| DHR | DANAHER CORP | 25.87 | 153.038B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 151.16 | 49.868B | ||
| A | AGILENT TECHNOLOGIES INC | 21.31 | 36.146B | ||
| IQV | IQVIA HOLDINGS INC | 13.95 | 32.812B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 30.29 | 28.211B | ||
| WAT | WATERS CORP | 22.6 | 19.534B | ||
| ILMN | ILLUMINA INC | 23.05 | 17.916B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 31.03 | 17.908B | ||
| MEDP | MEDPACE HOLDINGS INC | 26.53 | 14.94B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About SEER
Company Profile
Seer, Inc. (California) engages in the development of proprietary engineered nanoparticles to provide access across the proteome. The company is headquartered in Redwood City, California and currently employs 134 full-time employees. The company went IPO on 2020-12-04. The company is developing products that open a new gateway to the proteome. Its Proteograph product suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform proteomic analysis at scale in a matter of hours. The Proteograph has detected over 36,000 proteins across multiple species, and its performance and capabilities have been demonstrated in over 33 peer-reviewed publications, preprints and reviews. The Proteograph Product Suite is detector-agnostic and is adaptable to other protein detection instruments. The MS component of the Proteograph workflow is either provided by the researcher’s laboratory, can be outsourced to a third-party provider, or be run through the Seer Technology Access Center (STAC), which is its in-house service program. The company has launched Proteograph XT, which enhances the sample throughput of the Proteograph Product Suite and MS instrument.
Company Info
SEER INC
3800 Bridge Parkway, Suite 102
Redwood City CALIFORNIA US
Employees: 134
Phone: 16504530000
SEER INC / SEER FAQ
Can you describe the business of SEER INC?
Seer, Inc. (California) engages in the development of proprietary engineered nanoparticles to provide access across the proteome. The company is headquartered in Redwood City, California and currently employs 134 full-time employees. The company went IPO on 2020-12-04. The company is developing products that open a new gateway to the proteome. Its Proteograph product suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform proteomic analysis at scale in a matter of hours. The Proteograph has detected over 36,000 proteins across multiple species, and its performance and capabilities have been demonstrated in over 33 peer-reviewed publications, preprints and reviews. The Proteograph Product Suite is detector-agnostic and is adaptable to other protein detection instruments. The MS component of the Proteograph workflow is either provided by the researcher’s laboratory, can be outsourced to a third-party provider, or be run through the Seer Technology Access Center (STAC), which is its in-house service program. The company has launched Proteograph XT, which enhances the sample throughput of the Proteograph Product Suite and MS instrument.
What is the current price of SEER stock?
The current stock price of SEER is 1.77 USD. The price decreased by -2.21% in the last trading session.
What is the dividend status of SEER INC?
SEER does not pay a dividend.
What is the ChartMill technical and fundamental rating of SEER stock?
SEER has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
How many employees does SEER INC have?
SEER INC (SEER) currently has 134 employees.
When does SEER INC (SEER) report earnings?
SEER INC (SEER) will report earnings on 2026-02-26, after the market close.